CareFusion 303, Inc.
Case
•
[2021] APO 12
•26 February 2021
Details
AGLC
Case
Decision Date
CareFusion 303, Inc. [2021] APO 12
[2021] APO 12
26 February 2021
CaseChat Overview and Summary
CareFusion 303, Inc. is the applicant seeking patent protection for a system and method for managing the retrieval of prepared medications within a healthcare facility. The dispute before the court revolved around the patentability of the invention, particularly whether the claims pertained to a scheme or a manner of manufacture. The court was tasked with determining whether the invention, as defined by the claims, constituted a patentable scheme rather than a non-patentable manner of manufacture.
The court began by examining the nature of the invention, which involved a system for managing the retrieval of prepared medications through the use of active identification devices, reader devices, and a network. The court considered whether the invention's contribution lay in the generation and arrangement of intellectual information or in the implementation of a scheme using generic computing technology. The court found that while the invention did involve the generation of information, the primary contribution lay in the scheme for ordering the retrieval of unused medications to achieve a practical and useful result, namely reducing pharmaceutical wastage. The court noted that the use of a computer system was integral to the invention due to the time-critical nature of the steps involved.
The court then weighed various considerations to determine whether the invention was a scheme or a manner of manufacture. It found that the weight accorded to the practical and useful result was insufficient to disturb the balance of considerations, leading the court to conclude that the contribution to the invention was a scheme. The court acknowledged that the potential for a practical and useful result was linked to the invention but not guaranteed, resulting in a minimal weight being given to this consideration. Consequently, the court concluded that the invention defined by the claims was a scheme.
In light of the court's findings, it allowed the applicant the opportunity to amend the specification in line with the decision, suggesting that it might be possible to improve the balance of considerations through amendments to the claims. The court did not make any final orders in this regard but left the door open for the applicant to pursue amendments to the claims if they wished to do so.
The court began by examining the nature of the invention, which involved a system for managing the retrieval of prepared medications through the use of active identification devices, reader devices, and a network. The court considered whether the invention's contribution lay in the generation and arrangement of intellectual information or in the implementation of a scheme using generic computing technology. The court found that while the invention did involve the generation of information, the primary contribution lay in the scheme for ordering the retrieval of unused medications to achieve a practical and useful result, namely reducing pharmaceutical wastage. The court noted that the use of a computer system was integral to the invention due to the time-critical nature of the steps involved.
The court then weighed various considerations to determine whether the invention was a scheme or a manner of manufacture. It found that the weight accorded to the practical and useful result was insufficient to disturb the balance of considerations, leading the court to conclude that the contribution to the invention was a scheme. The court acknowledged that the potential for a practical and useful result was linked to the invention but not guaranteed, resulting in a minimal weight being given to this consideration. Consequently, the court concluded that the invention defined by the claims was a scheme.
In light of the court's findings, it allowed the applicant the opportunity to amend the specification in line with the decision, suggesting that it might be possible to improve the balance of considerations through amendments to the claims. The court did not make any final orders in this regard but left the door open for the applicant to pursue amendments to the claims if they wished to do so.
Details
Key Legal Topics
Areas of Law
-
Intellectual Property Law
Legal Concepts
-
Patents
-
Contribution to the Invention
-
Scheme vs. Manner of Manufacture
Actions
Download as PDF
Download as Word Document
Citations
CareFusion 303, Inc. [2021] APO 12
Most Recent Citation
CareFusion 303, Inc. [2023] APO 17
Cases Citing This Decision
6
DEI GRATIA PTY LTD
[2023] APO 50
CareFusion 303, Inc.
[2023] APO 17
CareFusion 303, Inc.
[2022] APO 40